Vimedimex Medi-Pharma JSC (HOSE:VMD)
Vietnam · Delayed Price · Currency is VND 12,400
0.00 (0.00%)
At close: Nov 3, 2026
Vimedimex Medi-Pharma JSC Revenue
Vimedimex Medi-Pharma JSC had revenue of 48.50B VND in the quarter ending September 30, 2026, a decrease of -64.88%. This brings the company's total for the last twelve months to 310.29B, down -68.76% year-over-year. In the year 2025, Vimedimex Medi-Pharma JSC had annual revenue of 812.98B, down -34.95%. That makes Vimedimex Medi-Pharma JSC the 36,512th largest company in the world by revenue and 523rd in Vietnam.
Revenue (ttm)
310.29B
Revenue Growth
-68.76%
P/S Ratio
0.62
Revenue / Employee
8.87B
Employees
35
Market Cap
191.46B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 812.98B | -436.89B | -34.95% |
| Jan 1, 2025 | 1.25T | -2.29T | -64.66% |
| Dec 31, 2023 | 3.54T | -3.54T | -50.00% |
| Jan 1, 2023 | 7.07T | -5.25T | -42.58% |
| Dec 31, 2021 | 12.32T | -5.84T | -32.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vidipha Central Pharmaceutical JSC | 1.01T |
| Ben Tre Pharmaceutical JSC | 873.41B |
| Pharmedic Pharmaceutical Medicinal JSC | 565.40B |
| Central Pharmaceutical Joint Stock Company No3 | 524.41B |
| Mediplantex National Pharmaceutical JSC | 434.97B |
| Lamdong Pharmaceutical JSC | 278.17B |
| SPM Corporation | 202.60B |
| Phong Phu Pharmaceutical JSC | 167.82B |